ARNI-ARVC by National Institute of Cardiology
Sacubitril/valsartan in preventing disease progression in patients with arrhythmogenic right ventricular cardiomyopathy - the ARNI-ARVC multi-site randomized trial
Selected study environments
Logging area
Selected research projects supported by diCELLa.
This area presents a curated view of study environments, phases, and therapeutic or operational areas where diCELLa has supported research teams. It is not a complete catalogue of all diCELLa work.
Open studies
Examples of studies currently in preparation or recruitment.
These selected projects remain active inside the diCELLa environment and show the kind of phase, area, and operational context our platform can support.
CADET-PAD by Jagiellonian University Medical College
The assessment of cysteinyl leukotriene receptor antagonist role in inhibition of atherosclerosis, proliferation and its influence on endothelial function in patients undergoing endovascular treatment due to peripheral arterial disease
CASCADES trial by National Institute of Cardiology
A randomized, ongoing, open clinical trial evaluating the anti-atherosclerotic efficacy of selected antidiabetic medications in patients with coronary artery disease and pre-diabetic conditions.
ChIm-NB-PL by Jagiellonian University Medical College
Immunotherapy with dinutuximab beta in combination with chemotherapy for the treatment of patients with primary neuroblastoma refractory to standard therapy and with relapsed or progressive disease
DICES by Collegium Medicum
Diffrent Iodine Contrast media Effectiveness and Safety in Contrast Enhanced Mammography
DuoNen by National Center for Nuclear Research, POLATOM Radioisotope Center
Tandem therapy LutaPol/ItraPol (177Lu / 90Y-DOTATATE) as an effective method in the treatment of neuroendocrine neoplasms
EMPA-REPAIR-HCM by National Institute of Cardiology
The Use of Empagliflozin in Patients With Hypertrophic Cardiomyopathy
LevoTako by Medical University of Gdansk
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study of Levosimendan Therapy in low ejection fraction Takotsubo Syndrome (LevoTako Trial)
OPTIMAL – HT by National Institute of Cardiology
Optimal medical treatment of difficult-to-treat hypertension
POSTCOVID by Eleonora Reicher National Institute of Geriatrics, Rheumatology and Rehabilitation in Warsaw
Investigation of Pregabalin Therapy and Complex Rehabilitation in Treating Chronic Fatigue Associated With Post-COVID Syndrome
RAFTING by Medical University of Gdansk
Radiation-Free Therapy for the Initial treatment of Good prognosis early non-bulky HL, defined by a low Metabolic Tumor Volume and a negative interim PET after 2 chemotherapy cycles- RAFTING
SAFE LAAC by National Institute of Cardiology
Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure (SAFE-LAAC)
SAFE LAAC CKD by National Institute of Cardiology
Optimal Antiplatelet Treatment to Achieve Stroke Avoidance and Fall in Bleeding Events following Left Atrial Appendage Closure – Chronic Kidney Disease (SAFE LAAC CKD). Comparative Health Effectiveness Ancillary Study – PILOT
STOP CLOT by National Institute of Cardiology
Strategy To Optimize PeriproCeduraL AnticOagulation in Structural Transseptal Interventions (STOP CLOT Trial)
The SIBERIA II Trial by Meshalkin Research Institute of Pathology of Circulation
Independent Randomized Clinical Trial in Carotid Revascularization with MicroNet Covered Stent (CGuard) Comparing Early Neurological Outcomes with distal EPS Versus Proximal EPS. The SIBERIA II Trial
Completed studies
Selected completed project references.
Closed studies remain visible as selected reference records, with key project information available in the same structured format.